iifl-logo

Sudarshan Pharma Industries Ltd EGM

29.03
(1.86%)
Jul 18, 2025|12:00:00 AM

Sudarshan Pharma CORPORATE ACTIONS

22/07/2024calendar-icon
22/07/2025calendar-icon
PurposeAnnouncement DateMeeting Date
EGM16 May 202512 Jun 2025
Pursuant to Regulation 34 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 please find enclosed the Notice of Extraordinary General Meeting to be held on 12/June/2025 at 3.00 pm IST through video conferencing / other audio visual means. Pursuant to Regulation 30 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 we enclose herewith the summary of the proceedings of the Extraordinary General Meeting of the Company held on 12th June 2025 at 3.00 p.m. through video conferencing / other audio visual means. (As Per BSE Announcement Dated on: 12.06.2025) Pursuant to Regulation 44 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, please find enclosed the Scrutinizers Report on the business transacted at the Extraordinary General Meeting of the Company held on Thursday, 12th June 2025 through video conferencing / other audio-visual means. (As Per BSE Announcement Dated on :14.06.2025)
EGM10 Jan 20254 Feb 2025
Raising of funds by way of creating, issuing and allotting up to 4,30,00,000 (Four Crores Thirty Lakhs Only) Fully Convertible Warrants Convertible into equivalent number of fully paid-up equity shares of the Company having face value of Re.1/- (Rupee One Only), in one or more tranches, to the persons belonging to Promoter / Promoter Group and Non-Promoter, Public Category Please find enclosed the newspaper publication for the Notice of Extraordinary General Meeting to be held on Tuesday, 04/February/2025 at 3.00 pm IST through video conferencing / other audio visual means published in (i) Mumbai Lakshdeep and (ii) Financial Express (As per BSE Announcement Dated on 14/01/2025) We inform you that an Extraordinary General Meeting of the Company was held on Tuesday, 4th February 2025 at 3.00 pm through video conferencing / other audio visual means. Pursuant to Regulation 30 and part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a summary of the proceedings of Extraordinary General Meeting. (As Per BSE Announcement Dated on: 04/02/2025) Pursuant to Regulation 44 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, please find enclosed the voting results on the business transacted at the Extraordinary General Meeting of the Company held on Tuesday, 4th February 2025 at 3.00 pm through video conferencing / other audio-visual means. (As Per BSE Announcement Dated on: 05/02/2025)
EGM6 Sep 202430 Sep 2024
EGM 30/09/2024 We enclose the Voting Results of the Extraordinary General Meeting of the Company held on Monday, 30th September 2024 at 5.00 pm through video conferencing / other audio visual means. An Extraordinary General Meeting of the Company is scheduled to be held on Monday, 30-September-2024 at 5.00 pm IST through video conferencing / other audio video means (As Per BSE Announcement Dated on: 05/09/2024) We enclose the Scrutinizers Report for the Extraordinary General Meeting of the Company held on Monday, 30th September 2024 at 5.00 pm through video conferencing / other audio visual means. (As Per BSE Announcement Dated on 01.10.2024) Please find enclosed the revised voting results on the business transacted at the Extraordinary General Meeting held on 30/09/2024 through video conferencing / other audio visual means, along with remote e-voting done by the members eligible to do so as per the Addendum issued by the Company as per the instructions of BSE Limited Please find enclosed the Scrutinizers Report on the business transacted at the Extraordinary General Meeting held on 30/09/2024 through video conferencing / other audio visual means along with remote e-voting done by the members eligible to do so as per the Addendum issued by the Company as per the instructions of BSE Limited. (As per BSE Announcement Dated on 21/11/2024)

Sudarshan Pharma: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.